Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Recent studies add new data to cervical cancer research
June 16th, 2005
Investigators in Wales, Sweden and the United States have published new cervical cancer data. Study 1: Investigators describe the immunotherapeutic potential of a human HPV16 E7-specific cytotoxic T lymphocyte (CTL) line in a recent issue of the International Journal of Cancer. "Cervical cancer (CaCx) is strongly associated with human papillomavirus (HPV) infection, particularly HPV types 16 and 18. The constitutive expression of HPV E6 and E7 proteins in CaCx makes them attractive targets for CTL based immunotherapy. However cervical carcinomas may have features (e.g., antigen processing defects) that limit the effectiveness of HPV specific...
Source: Women's Health Weekly (2005-06-16)
|
